Literature DB >> 24818627

Effects of right ventricular dysfunction on exercise capacity and quality of life and associations with serum NT-proBNP levels in COPD: an observational study.

Tuğce Sahin Ozdemirel1, Sevinç Sarinç Ulaşli, Begüm Yetiş, Emir Karaçağlar, Nilüfer Bayraktar, Gaye Ulubay.   

Abstract

OBJECTIVE: During the course of chronic obstructive pulmonary disease (COPD), pulmonary hypertension (PH) and right ventricular (RV) failure may develop due to elevated afterload of the RV. In those patients, exercise capacity is reduced due to pulmonary and cardiac limitations. We investigated relationships between serum N-terminal of proB-type natriuretic peptide (NT-proBNP) and RV functions with exercise capacity and quality of life in patients COPD.
METHODS: An observational case-control study was conducted. We enrolled 31 moderate and severe COPD patients, and 20 subjects without chronic diseases as control group. Parameters reflecting the right ventricular diastolic and systolic functions by echocardiography along with serum NT-proBNP levels were assessed. Cardiopulmonary exercise testing and Short Form-36 (SF-36) were applied.
RESULTS: Serum NT-proBNP levels were higher in COPD patients than control group (p=0.003). Serum NT-proBNP level was found to be related with pulmonary arterial pressure. Serum NT-proBNP levels were negatively correlated with anaerobic threshold oxygen uptake (AT VO2) and peak oxygen uptake (PVO2) values. Early ventricular filling velocity (Em) was lower in COPD patients. Em wave was significantly correlated with O2 pulse. There was a positive relationship between tricuspid E/A ratio and VO2 value at AT. SF-36 domains of physical functioning, general health and role limitation due to physical disorder were significantly correlated with AT VO2, PVO2 and O2 pulse.
CONCLUSION: Exercise limitation may be predicted by assessment of right ventricule functions and NT-proBNP levels and exercise limitation impairs quality of life in COPD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24818627     DOI: 10.5152/akd.2014.4687

Source DB:  PubMed          Journal:  Anadolu Kardiyol Derg        ISSN: 1302-8723


  4 in total

1.  Comparison of Functional Capacity and Symptoms of COPD Patients with and without Pulmonary Hypertension.

Authors:  Fikriye Kalkan; Elif Yilmazel Ucar; Kamuran Kalkan; Omer Araz
Journal:  Eurasian J Med       Date:  2020-06-02

2.  Preventive effect of sildenafil on right ventricular function in rats with monocrotaline-induced pulmonary arterial hypertension.

Authors:  Rieko Yoshiyuki; Ryo Tanaka; Ryuji Fukushima; Noboru Machida
Journal:  Exp Anim       Date:  2016-02-12

Review 3.  B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.

Authors:  Nathaniel M Hawkins; Amit Khosla; Sean A Virani; John J V McMurray; J Mark FitzGerald
Journal:  BMC Pulm Med       Date:  2017-01-10       Impact factor: 3.317

4.  Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.

Authors:  Haiqing Li; Zixiong Zeng; Juan Cheng; Guoping Hu; Yuqun Li; Liping Wei; Yumin Zhou; Pixin Ran
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.